The Sodium-Glucose Co-Transporter 2 Inhibitor, Empagliflozin, Protects against Diabetic Cardiomyopathy by Inhibition of the Endoplasmic Reticulum Stress Pathway - Concepedia

Concepedia

Publication | Open Access

The Sodium-Glucose Co-Transporter 2 Inhibitor, Empagliflozin, Protects against Diabetic Cardiomyopathy by Inhibition of the Endoplasmic Reticulum Stress Pathway

DOI Full Paper Access

65

Citations

33

References

2017

Year

Yang Zhou, Wei Wu

Cellular Physiology and Biochemistry

Abstract

EMPA protects against DCM by inactivating the endoplasmic reticulum stress pathway.

References

	Year	Citations

Page 1